CO4950520A1 - Formulaciones parenterales de 5h-dibenz (b,f) azepin-5- carboxiamidas utiles en el tratamiento de ataques epilepti- cos - Google Patents
Formulaciones parenterales de 5h-dibenz (b,f) azepin-5- carboxiamidas utiles en el tratamiento de ataques epilepti- cosInfo
- Publication number
- CO4950520A1 CO4950520A1 CO98057677A CO98057677A CO4950520A1 CO 4950520 A1 CO4950520 A1 CO 4950520A1 CO 98057677 A CO98057677 A CO 98057677A CO 98057677 A CO98057677 A CO 98057677A CO 4950520 A1 CO4950520 A1 CO 4950520A1
- Authority
- CO
- Colombia
- Prior art keywords
- dibenz
- azepin
- water
- parenteral formulation
- carboxiamides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La presente invención se relaciona con una formulaciónparenteral que comprende una 5H-dibenz(b,f)azepin- 5-carboxamida y agua o un solvente basado en agua, en donde la formulación no contiene otros auxiliares de solubilización.Una formulación parenteral que comprende una 5H- dibenz(b,f)azepin-5-carboxamida, agua o un solvente basado en agua, y glucosa. Una formulación parenteral que comprende 10- hidroxi-10,11-tetrahidrocarbamazepina y agua.Una formulación parenteral de acuerdo con la reivindicación 3, la cual comprende adicionalmente un agente isotónico. Una formulación parenteral de acuerdo con la reivindicación 3 o con la reivindicación 4, en donde el agente isotónico es glucosa. Una formulación parenteral de acuerdo con la reivindicación 2 y 5, en donde la glucosa está presente en una cantidad del 4.75 por ciento en peso, basándose en el peso total de la formulación parenteral. Una forma de dosificación unitaria que comprende una cantidad efectiva de una 5H-dibenz(b,f)azepin-5- carboxamida y agua, o un solvente basado en agua, en donde la forma de dosificación unitaria no contiene otros auxiliares de solubilización.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9721497.7A GB9721497D0 (en) | 1997-10-09 | 1997-10-09 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4950520A1 true CO4950520A1 (es) | 2000-09-01 |
Family
ID=10820342
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98057677A CO4950520A1 (es) | 1997-10-09 | 1998-10-05 | Formulaciones parenterales de 5h-dibenz (b,f) azepin-5- carboxiamidas utiles en el tratamiento de ataques epilepti- cos |
| CO98057677D CO5090854A1 (es) | 1997-10-09 | 1998-10-05 | Recipiente que contiene formulaciones parenterales de 5h- dibenz (b,f)azepin-5-carboxamidas utiles en el tratamiento de ataques epilepticos |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98057677D CO5090854A1 (es) | 1997-10-09 | 1998-10-05 | Recipiente que contiene formulaciones parenterales de 5h- dibenz (b,f)azepin-5-carboxamidas utiles en el tratamiento de ataques epilepticos |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6316417B1 (es) |
| EP (1) | EP1033988B1 (es) |
| JP (2) | JP2001519395A (es) |
| KR (1) | KR100760326B1 (es) |
| CN (1) | CN1210032C (es) |
| AR (1) | AR015465A1 (es) |
| AT (1) | ATE257383T1 (es) |
| AU (1) | AU748034B2 (es) |
| BR (1) | BR9812861A (es) |
| CA (1) | CA2304661C (es) |
| CO (2) | CO4950520A1 (es) |
| CZ (1) | CZ298900B6 (es) |
| DE (1) | DE69821024T2 (es) |
| DK (1) | DK1033988T3 (es) |
| ES (1) | ES2214738T3 (es) |
| GB (1) | GB9721497D0 (es) |
| HK (1) | HK1031824A1 (es) |
| HU (1) | HU226106B1 (es) |
| ID (1) | ID24134A (es) |
| IL (1) | IL135123A0 (es) |
| MY (1) | MY122129A (es) |
| NO (1) | NO327263B1 (es) |
| NZ (1) | NZ503526A (es) |
| PE (1) | PE121998A1 (es) |
| PL (1) | PL192287B1 (es) |
| PT (1) | PT1033988E (es) |
| RU (1) | RU2242231C2 (es) |
| SK (1) | SK286253B6 (es) |
| TR (1) | TR200000870T2 (es) |
| TW (1) | TW584563B (es) |
| WO (1) | WO1999018966A1 (es) |
| ZA (1) | ZA989183B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| EP1928464B1 (en) * | 2005-09-30 | 2014-05-14 | Lundbeck Inc. | Novel parenteral carbamazepine formulation |
| US20100204178A1 (en) | 2006-10-02 | 2010-08-12 | James Cloyd | Novel parenteral carbamazepine formulation |
| BRPI0707612B8 (pt) * | 2006-02-09 | 2021-05-25 | Macusight Inc | vaso lacrado e formulações líquidas contidas no mesmo |
| US8372431B2 (en) | 2007-10-26 | 2013-02-12 | Bial-Portela & C.A., S.A. | Pharmaceutical composition comprising licarbazepine acetate |
| CN101711739B (zh) * | 2008-10-08 | 2012-07-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 卡马西平的口服药物组合物 |
| CN105726466A (zh) * | 2014-12-10 | 2016-07-06 | 辽宁药联制药有限公司 | 一种奥卡西平注射剂及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2081965T3 (es) * | 1989-12-27 | 1996-03-16 | Ciba Geigy Ag | Dispositivo para homogenizar la distribuccion no homogenea de la luz de un haz de rayos laser. |
| EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
| US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
| US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
| FR2702148B1 (fr) | 1993-03-05 | 1995-04-07 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement du neuro-sida. |
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US5466683A (en) * | 1994-08-25 | 1995-11-14 | Teva Pharmaceutical Industries Ltd. | Water-soluble analogs of carbamazepine |
-
1997
- 1997-10-09 GB GBGB9721497.7A patent/GB9721497D0/en not_active Ceased
-
1998
- 1998-09-17 TW TW087115501A patent/TW584563B/zh not_active IP Right Cessation
- 1998-10-05 CO CO98057677A patent/CO4950520A1/es unknown
- 1998-10-05 CO CO98057677D patent/CO5090854A1/es unknown
- 1998-10-07 AT AT98950110T patent/ATE257383T1/de not_active IP Right Cessation
- 1998-10-07 PT PT98950110T patent/PT1033988E/pt unknown
- 1998-10-07 ID IDW20000588A patent/ID24134A/id unknown
- 1998-10-07 IL IL13512398A patent/IL135123A0/xx unknown
- 1998-10-07 RU RU2000110741/15A patent/RU2242231C2/ru not_active IP Right Cessation
- 1998-10-07 AU AU96298/98A patent/AU748034B2/en not_active Ceased
- 1998-10-07 DK DK98950110T patent/DK1033988T3/da active
- 1998-10-07 TR TR2000/00870T patent/TR200000870T2/xx unknown
- 1998-10-07 EP EP98950110A patent/EP1033988B1/en not_active Expired - Lifetime
- 1998-10-07 CN CNB988099888A patent/CN1210032C/zh not_active Expired - Fee Related
- 1998-10-07 PL PL339446A patent/PL192287B1/pl not_active IP Right Cessation
- 1998-10-07 NZ NZ503526A patent/NZ503526A/xx unknown
- 1998-10-07 WO PCT/EP1998/006382 patent/WO1999018966A1/en active IP Right Grant
- 1998-10-07 KR KR1020007003210A patent/KR100760326B1/ko not_active IP Right Cessation
- 1998-10-07 AR ARP980105003A patent/AR015465A1/es unknown
- 1998-10-07 HU HU0004362A patent/HU226106B1/hu not_active IP Right Cessation
- 1998-10-07 ES ES98950110T patent/ES2214738T3/es not_active Expired - Lifetime
- 1998-10-07 PE PE1998000950A patent/PE121998A1/es not_active Application Discontinuation
- 1998-10-07 JP JP2000515601A patent/JP2001519395A/ja not_active Withdrawn
- 1998-10-07 BR BR9812861-2A patent/BR9812861A/pt not_active Application Discontinuation
- 1998-10-07 DE DE69821024T patent/DE69821024T2/de not_active Expired - Lifetime
- 1998-10-07 CZ CZ20001279A patent/CZ298900B6/cs not_active IP Right Cessation
- 1998-10-07 CA CA002304661A patent/CA2304661C/en not_active Expired - Fee Related
- 1998-10-07 US US09/509,973 patent/US6316417B1/en not_active Expired - Fee Related
- 1998-10-07 MY MYPI98004586A patent/MY122129A/en unknown
- 1998-10-07 SK SK505-2000A patent/SK286253B6/sk not_active IP Right Cessation
- 1998-10-08 ZA ZA989183A patent/ZA989183B/xx unknown
-
2000
- 2000-04-04 NO NO20001730A patent/NO327263B1/no not_active IP Right Cessation
-
2001
- 2001-02-13 HK HK01101037A patent/HK1031824A1/xx not_active IP Right Cessation
- 2001-11-09 US US10/037,090 patent/US6458770B1/en not_active Expired - Fee Related
-
2005
- 2005-05-06 JP JP2005135218A patent/JP2005281314A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2174465T3 (es) | Compuestos triazol y su utilizacion como ligandos de dopamina-d. | |
| DE60104206D1 (de) | Halbfeste arzneizubereitung enthaltend isotretinoin | |
| KR890004709A (ko) | 항원충제로서의 아지트로마이신 및 이의 유도체 | |
| PE84899A1 (es) | Formulaciones farmaceuticas que contienen voriconazol | |
| PE44895A1 (es) | Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero | |
| BR9913932A (pt) | Uso de análogos de glp-1 no tratamento de derrame | |
| ES2196160T3 (es) | Uso de una combinacion de tensioactivos, agentes quelantes y aceites esenciales para desinfeccion efectiva. | |
| UY26391A1 (es) | Inhibidores sglt2 de glucosidos de c-arilo y metodo | |
| YU60900A (sh) | Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja | |
| ES2172024T3 (es) | Composicion para el tratamiento del cabello que contiene un complejo de aminoacido-metal. | |
| EA200100298A1 (ru) | ФАРМАЦЕВТИЧЕСКИЕ ПРЕПАРАТЫ С РЕГУЛИРУЕМЫМ ВЫСВОБОЖДЕНИЕМ, СОДЕРЖАЩИЕ ИНГИБИТОР cGMP-ФОСФОДИЭСТЕРАЗЫ-5 | |
| PE20010053A1 (es) | Formulacion de amoxicilina y clavulanato de potasio | |
| GT199900067A (es) | Nuevas 4-fenilpiperidinas para el tratamiento dedermatosis prurìtica. | |
| PA8502901A1 (es) | Tratamiento de combinacion con il-1ra y compuestos que inhiben el procesamiento y la liberacion de il-1 | |
| AR029288A1 (es) | Derivados de 1-sulfonil-pirrolidina | |
| AR024959A1 (es) | Una composicion farmaceutica liquida basada en paracetamol | |
| BR0012696A (pt) | Composição oftálmica | |
| CO4950520A1 (es) | Formulaciones parenterales de 5h-dibenz (b,f) azepin-5- carboxiamidas utiles en el tratamiento de ataques epilepti- cos | |
| BR9910024A (pt) | Agente contra resfriado | |
| GT199900129A (es) | Formulaciones liquidas de pirimetanilo y metodos para su preparacion. | |
| ES2104141T5 (es) | Dispositivo iontoforetico apto para ser activado por el usuario. | |
| ES2110058T3 (es) | Composicion de silicona dispersable en agua. | |
| AR028411A1 (es) | Secuencias de nuclentidos relacionadas con el aumento o la disminucion del endice de ovulacion en mameferos | |
| ES2095345T3 (es) | Composiciones adhesivas a base de agua para poliolefinas. | |
| BR0010699A (pt) | Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários |